rosiglitazone has been researched along with leupeptins in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bluher, M; Faber, R; Fasshauer, M; Köhler, U; Kralisch, S; Kratzsch, J; Lössner, U; Schubert, A; Sommer, G; Stangl, V; Stepan, H; Stumvoll, M; Vietzke, A | 1 |
1 other study(ies) available for rosiglitazone and leupeptins
Article | Year |
---|---|
Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB.
Topics: Adipocytes; Adipokines; Apoptosis; Cell Adhesion; Cells, Cultured; E-Selectin; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Leptin; Leupeptins; NF-kappa B; Resistin; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2008 |